TY - JOUR
T1 - Parathyroid hormone
T2 - A double-edged sword for bone metabolism
AU - Qin, Ling
AU - Raggatt, Liza J.
AU - Partridge, Nicola C.
PY - 2004/3
Y1 - 2004/3
N2 - Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.
AB - Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.
UR - http://www.scopus.com/inward/record.url?scp=1342329522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1342329522&partnerID=8YFLogxK
U2 - 10.1016/j.tem.2004.01.006
DO - 10.1016/j.tem.2004.01.006
M3 - Review article
C2 - 15036251
AN - SCOPUS:1342329522
SN - 1043-2760
VL - 15
SP - 60
EP - 65
JO - Trends in Endocrinology and Metabolism
JF - Trends in Endocrinology and Metabolism
IS - 2
ER -